Interaction between p53 Mutation and a Somatic HDMX Biomarker Better Defines Metastatic Potential in Breast Cancer

Author(s):
Grawenda, A.M.; Moller, E.K.; Lam, S.; Repapi, E.; Teunisse, A.F.A.S.; Alnaes, G.I.G.; Borresen-Dale, A.L.; Kristensen, V.N.; Goding, C.R.; Jochemsen, A.G. (0000-0002-0570-7967); Edvardsen, H.; Bond, G.L.
Published
2015
Publication type
Article / Letter to editor
Date issued
2015-02-15
Language
English
Is part of
hdl
1887/103115
doi
10.1158/0008-5472.CAN-14-2637